Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Interv Cardiol Clin. 2020 Jul;9(3):357-367. doi: 10.1016/j.iccl.2020.02.010. Epub 2020 May 7.
Chronic kidney disease patients have a high prevalence of severe valvular heart disease, which reduces life expectancy. Transcatheter valve interventions has revamped the way we manage severe valvular heart disease and are an attractive alternative to invasive surgery in patients with chronic kidney disease and severe valvular heart disease. This review summarizes the impact of transcatheter valve interventions in patients with severe valvular heart disease and chronic kidney disease.
慢性肾脏病患者的严重瓣膜性心脏病患病率很高,这降低了预期寿命。经导管瓣膜介入治疗改变了我们治疗严重瓣膜性心脏病的方式,对于慢性肾脏病和严重瓣膜性心脏病患者来说,这是一种有吸引力的侵入性手术替代方法。本文综述了经导管瓣膜介入治疗对严重瓣膜性心脏病合并慢性肾脏病患者的影响。